Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$194M |
| 2 |
Oracle
ORCL
|
+$159M |
| 3 |
AutoZone
AZO
|
+$159M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$157M |
| 5 |
Merck
MRK
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$881M |
| 2 |
Blackstone
BX
|
+$367M |
| 3 |
Toronto Dominion Bank
TD
|
+$297M |
| 4 |
Scotiabank
BNS
|
+$264M |
| 5 |
Netflix
NFLX
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.8% |
| 2 | Miscellaneous | 15.16% |
| 3 | Technology | 10.24% |
| 4 | Energy | 8.8% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3626
Akebia Therapeutics
AKBA
$241M
| $57K | ﹤0.01% |
11,856
+11,105
| +1,479% | +$63.2K |
2014 Q4
18 quarters
|
|
|
EFT
3627
Eaton Vance Floating-Rate Income Trust
EFT
$285M
| $57K | ﹤0.01% |
4,250
| – | – |
2016 Q2
12 quarters
|
|
3628
Forestar Group
FOR
$1.33B
| $57K | ﹤0.01% |
2,910
+881
| +43% | +$16.3K |
2013 Q2
24 quarters
|
|
|
NCV
3629
Virtus Convertible & Income Fund
NCV
$339M
| $57K | ﹤0.01% |
2,500
| – | – |
2017 Q2
8 quarters
|
|
3630
Parsons
PSN
$4.38B
| $57K | ﹤0.01% |
+1,559
| New | +$51.1K |
2019 Q2
0 quarters
|
|
|
HMTV
3631
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $57K | ﹤0.01% |
4,362
+1,529
| +54% | +$21.4K |
2015 Q4
14 quarters
|
|
3632
Anika Therapeutics
ANIK
$259M
| $56K | ﹤0.01% |
1,373
-43,827
| -97% | -$1.6M |
2013 Q3
23 quarters
|
|
3633
Crawford & Co Class A
CRD.A
$598M
| $56K | ﹤0.01% |
5,241
+1,381
| +36% | +$12.6K |
2013 Q2
24 quarters
|
|
3634
FS Bancorp
FSBW
$346M
| $56K | ﹤0.01% |
2,160
-4,888
| -69% | -$122K |
2017 Q4
6 quarters
|
|
3635
Midland States Bancorp
MSBI
$679M
| $56K | ﹤0.01% |
2,102
+1,835
| +687% | +$47.6K |
2016 Q4
10 quarters
|
|
3636
Northeast Bank
NBN
$1.07B
| $56K | ﹤0.01% |
2,015
-4,399
| -69% | -$93K |
2016 Q4
10 quarters
|
|
3637
iShares MSCI Global Gold Miners ETF
RING
$2.3B
| $56K | ﹤0.01% |
2,737
| – | – |
2019 Q1
1 quarter
|
|
3638
Sonida Senior Living
SNDA
$1.81B
| $56K | ﹤0.01% |
739
+296
| +67% | +$18.6K |
2017 Q3
7 quarters
|
|
3639
UroGen Pharma
URGN
$1.98B
| $56K | ﹤0.01% |
+1,564
| New | +$57.7K |
2019 Q2
0 quarters
|
|
3640
AudioEye
AEYE
$87.2M
| $55K | ﹤0.01% |
+7,000
| New | +$59.3K |
2019 Q2
0 quarters
|
|
3641
iShares MSCI Israel ETF
EIS
$879M
| $55K | ﹤0.01% |
+1,000
| New | +$54.5K |
2019 Q2
0 quarters
|
|
3642
iShares MSCI Brazil ETF
EWZ
$8.64B
| $55K | ﹤0.01% |
1,254
-207,631
| -99% | -$8.57M |
2013 Q2
24 quarters
|
|
3643
Insteel Industries
IIIN
$562M
| $55K | ﹤0.01% |
2,675
+702
| +36% | +$14.1K |
2015 Q4
14 quarters
|
|
3644
Schneider National
SNDR
$5.66B
| $55K | ﹤0.01% |
3,000
-71,606
| -96% | -$1.39M |
2017 Q2
8 quarters
|
|
3645
Wave Life Sciences
WVE
$765M
| $55K | ﹤0.01% |
2,106
+1,801
| +590% | +$50.5K |
2017 Q4
6 quarters
|
|
|
NETI
3646
DELISTED
Eneti Inc.
NETI
| $55K | ﹤0.01% |
1,281
+629
| +96% | +$26.9K |
2016 Q1
13 quarters
|
|
|
MMX
3647
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $55K | ﹤0.01% |
+12,500
| New | +$55K |
2019 Q2
0 quarters
|
|
|
ABTX
3648
DELISTED
Allegiance Bancshares
ABTX
| $55K | ﹤0.01% |
1,640
-2,742
| -63% | -$95K |
2017 Q1
9 quarters
|
|
|
RST
3649
DELISTED
ROSETTA STONE INC
RST
| $55K | ﹤0.01% |
2,391
+1,697
| +245% | +$40.8K |
2015 Q4
14 quarters
|
|
|
USFR
3650
DELISTED
WisdomTree Bloomberg Floating Rate Treasury Fund
USFR
| $55K | ﹤0.01% |
2,180
-4,000
| -65% | -$101K |
2018 Q4
2 quarters
|
|
Similar funds
Bank of Montreal's Q2 2019 Portfolio in Review
As of Q2 2019, Bank of Montreal held 5,259 positions worth $119B, up 1.9% from $117B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bank of Montreal's Q2 2019 filing shows 822 new, 2,226 increased, 1,465 reduced and 324 closed positions. Its largest new stake was Dow Inc: 1,346,158 shares worth $66.4M. The largest sale was Apple, an estimated $881M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Miscellaneous and Technology.
- Bank of Montreal's largest Q2 2019 buy was Dow Inc: 1,346,158 shares worth $66.4M.
- Bank of Montreal added most to Mastercard in Q2 2019, an estimated $194M increase.
- Bank of Montreal's biggest Q2 2019 reduction was Apple, cutting an estimated $881M.
- Bank of Montreal fully exited Goldcorp Inc in Q2 2019, selling an estimated $93M.
- Bank of Montreal's ten largest holdings make up 22% of its $119B portfolio in Q2 2019.
- Bank of Montreal opened 822 new positions and closed 324 in Q2 2019.
- Bank of Montreal's portfolio value rose 1.9% quarter-over-quarter to $119B.
Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.